Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CGONCG Oncology, Inc.

Nasdaq · CIK 0001991792
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts228

Identity from submissions API

NameCG Oncology, Inc.
CIK0001991792
TickersCGON
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN371611499
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(949) 409-3700
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
3000 PEGASUS PARK DRIVE
SUITE 1640
DALLAS
TX
75247
TX
Mailing address
3000 PEGASUS PARK DRIVE
SUITE 1640
DALLAS
TX
75247
TX

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

249 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-18 4 4 0001193125-26-467162 4582
2026-11-18 4 4 0001193125-26-467159 4934
2026-11-17 4 4 0001193125-26-465593 8220
2026-11-16 8-K 8-K 7.01,8.01,9.01 0001193125-26-462199 001-41925 261555609 34 17742120 1 1
2026-11-06 10-Q 10-Q 0001991792-26-000012 001-41925 261529554 34 5813924 1 1
2026-11-06 8-K 8-K 2.02,9.01 0001991792-26-000011 001-41925 261529497 34 266813 1 1
2026-10-19 4 4 0001193125-26-425297 5735
2026-10-19 4 4 0001193125-26-425295 10608
2026-10-19 3 3 0001193125-26-425256 13861
2026-10-15 144 xsl144X01/primary_doc.xml 0001950047-26-010274 001-41925 261463492 33 6449
2026-09-21 144 xsl144X01/primary_doc.xml 0001950047-26-009691 001-41925 261393857 33 21294
2026-09-17 144 xsl144X01/primary_doc.xml 0001950047-26-009639 001-41925 261387312 33 20540
2026-09-17 4 4 0001193125-26-394394 8712
2026-09-11 144 xsl144X01/primary_doc.xml 0001950047-26-009375 001-41925 261375186 33 19788
2026-09-02 144 xsl144X01/primary_doc.xml 0001950047-26-009036 001-41925 261355799 33 19041
2026-08-31 144 xsl144X01/primary_doc.xml 0001950047-26-008873 001-41925 261347280 33 18288
2026-08-27 144 xsl144X01/primary_doc.xml 0001950047-26-008793 001-41925 261331677 33 17534
2026-08-25 144 xsl144X01/primary_doc.xml 0001950047-26-008678 001-41925 261316332 33 16784
2026-08-24 144 xsl144X01/primary_doc.xml 0001950047-26-008634 001-41925 261311548 33 16031
2026-08-19 144 xsl144X01/primary_doc.xml 0001950047-26-008371 001-41925 261295199 33 15860
2026-08-18 4 4 0001193125-26-355561 8217
2026-08-17 144 xsl144X01/primary_doc.xml 0001950047-26-008205 001-41925 261286753 33 14527
2026-08-14 144 xsl144X01/primary_doc.xml 0001950047-26-008191 001-41925 261284245 33 13774
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097055 005-94327 261280914 34 23359
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000147 005-94327 261276159 34 10379
2026-08-13 144 xsl144X01/primary_doc.xml 0001950047-26-008109 001-41925 261274801 33 13021
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000902219-26-000242 005-94327 261273149 34 17335
2026-08-12 144 xsl144X01/primary_doc.xml 0001950047-26-008043 001-41925 261269018 33 12268
2026-08-11 144 xsl144X01/primary_doc.xml 0001950047-26-007989 001-41925 261264747 33 11515
2026-08-10 144 xsl144X01/primary_doc.xml 0001950047-26-007845 001-41925 261258299 33 10762
2026-08-07 144 xsl144X01/primary_doc.xml 0001950047-26-007823 001-41925 261254953 33 10008
2026-08-06 144 xsl144X01/primary_doc.xml 0001950047-26-007736 001-41925 261249340 33 9258
2026-08-06 10-Q 10-Q 0001193125-26-336918 001-41925 261246400 34 8941303 1 1
2026-08-06 8-K 8-K 2.02,8.01,9.01 0001193125-26-336886 001-41925 261246229 34 564245 1 1
2026-08-06 424B5 424B5 0001193125-26-336792 333-286230 261246099 33 309801 1 1
2026-08-05 144 xsl144X01/primary_doc.xml 0001950047-26-007711 001-41925 261244178 33 8505
2026-07-29 144 xsl144X01/primary_doc.xml 0001950047-26-007416 001-41925 261218064 33 7751
2026-07-28 144 xsl144X01/primary_doc.xml 0001950047-26-007370 001-41925 261212772 33 7001
2026-07-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002283 005-94327 261206145 34 11125
2026-07-27 144 xsl144X01/primary_doc.xml 0001950047-26-007310 001-41925 261205669 33 6248
2026-07-23 144 xsl144X01/primary_doc.xml 0001950047-26-007270 001-41925 261196992 33 5495
2026-07-17 4 4 0001193125-26-307838 8217
2026-07-15 144 xsl144X01/primary_doc.xml 0001950047-26-007109 001-41925 261177645 33 4742
2026-07-14 4 4 0001193125-26-303188 8722
2026-07-10 144 xsl144X01/primary_doc.xml 0001950047-26-007021 001-41925 261169183 33 6233
2026-07-01 144 xsl144X01/primary_doc.xml 0001950047-26-006790 001-41925 261146364 33 6228
2026-06-29 4 FORM 4 0001140361-26-026779 5149
2026-06-25 4 4 0001193125-26-282861 8214
2026-06-24 144 xsl144X01/primary_doc.xml 0001950047-26-006467 001-41925 261116409 33 6456
2026-06-23 4 4 0001193125-26-279543 8214
2026-06-22 144 xsl144X01/primary_doc.xml 0001950047-26-006393 001-41925 261107797 33 5737
2026-06-16 4 xslF345X06/form4-06162026_090604.xml 0001684531-26-000002 13926
2026-06-08 8-K 8-K 5.07 0001193125-26-261670 001-41925 261072523 34 150454 1 1
2026-06-05 4 4 0001193125-26-259700 5740
2026-06-05 4 4 0001193125-26-259693 5745
2026-06-05 4 4 0001193125-26-259691 5716
2026-06-05 4 4 0001193125-26-259705 10848
2026-06-05 4 4 0001193125-26-259690 5714
2026-06-05 4 4 0001193125-26-259688 5691
2026-06-04 144 xsl144X01/primary_doc.xml 0001950047-26-005645 001-41925 261065377 33 5017
2026-05-26 8-K 8-K 5.02 0001193125-26-237908 001-41925 261015969 34 156539 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001897612-26-000502 005-94327 26983407 34 7566
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000102 005-94327 26982483 34 12582
2026-05-08 10-Q 10-Q 0001193125-26-214669 001-41925 26958557 34 7793261 1 1
2026-05-08 8-K 8-K 2.02,9.01 0001193125-26-213440 001-41925 26956230 34 348916 1 1
2026-04-24 ARS ARS 0001193125-26-177430 001-41925 26894829 34 5107637
2026-04-24 DEFA14A DEFA14A 0001193125-26-177424 001-41925 26894803 34 1898633
2026-04-24 DEF 14A DEF 14A 0001193125-26-177395 001-41925 26894755 34 5698553 1 1
2026-04-20 4 4 0001193125-26-164013 8722
2026-04-17 144 xsl144X01/primary_doc.xml 0001950047-26-003597 001-41925 26872073 33 5741
2026-04-16 4 4 0001193125-26-159031 5507
2026-04-16 4 4 0001193125-26-159030 5508
2026-04-16 4 4 0001193125-26-159029 5526
2026-04-16 4 4 0001193125-26-159025 5576
2026-04-16 4 4 0001193125-26-159024 5506
2026-04-13 8-K 8-K 5.02,9.01 0001193125-26-152044 001-41925 26856536 34 450980 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-000918 005-94327 26799328 34 7185
2026-03-17 4 4 0001193125-26-110831 13084
2026-03-13 4 xslF345X05/form4-03132026_080321.xml 0002007101-26-000004 8862
2026-03-06 4 xslF345X05/form4-03062026_100310.xml 0002007101-26-000002 8871
2026-02-27 S-8 S-8 0001193125-26-079539 333-293839 26693076 33 530006 1 1
2026-02-27 10-K 10-K 0001193125-26-079498 001-41925 26693016 34 24791355 1 1
2026-02-27 8-K 8-K 2.02,9.01 0001193125-26-079452 001-41925 26692925 34 348786 1 1
2026-01-13 8-K 8-K 8.01,9.01 0001193125-26-011855 001-41925 26530654 34 160290 1 1
2026-01-13 424B5 424B5 0001193125-26-011846 333-286230 26530628 33 285425 1 1
2026-01-13 4 4 0001193125-26-011756 13097
2026-01-09 144 xsl144X01/primary_doc.xml 0001950047-26-000305 001-41925 26523453 33 5032
2026-01-09 8-K 8-K 7.01,8.01,9.01 0001193125-26-008329 001-41925 26521428 34 15949083 1 1
2025-11-26 4 4 0001193125-25-300645 5312
2025-11-26 3 3 0001193125-25-300536 19222
2025-11-26 8-K 8-K 5.02 0001193125-25-298160 001-41925 251523836 34 162423 1 1
2025-11-24 3 3 0001193125-25-293740 13540
2025-11-18 4 4 0001193125-25-286228 8090
2025-11-14 8-K 8-K 5.02 0001193125-25-283108 001-41925 251487103 34 163962 1 1
2025-11-14 10-Q 10-Q 0001193125-25-283000 001-41925 251486480 34 9981630 1 1
2025-11-14 8-K 8-K 2.02,9.01 0001193125-25-281672 001-41925 251481384 34 405762 1 1
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902219-25-000430 005-94327 251469857 34 17096
2025-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000082 005-94327 251434564 34 6231
2025-10-28 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001013594-25-001271 005-94327 251425815 34 28473
2025-10-15 4 4 0001193125-25-240271 8090
2025-10-10 4 4 0001193125-25-237104 8174
2025-10-09 144 xsl144X01/primary_doc.xml 0001950047-25-007869 001-41925 251385294 33 7921
2025-10-01 4 4 0001193125-25-226964 8588
2025-09-30 4 4 0001193125-25-225133 8589
2025-09-30 144 xsl144X01/primary_doc.xml 0001950047-25-007578 001-41925 251360869 33 7195
2025-09-22 4 4 0001193125-25-210015 13378
2025-09-18 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-207734 005-94327 251324742 34 133724
2025-09-18 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001013594-25-001163 005-94327 251324704 34 22506
2025-09-18 144 xsl144X01/primary_doc.xml 0001950047-25-007326 001-41925 251323801 33 5752
2025-09-16 4 4 0001193125-25-205003 8089
2025-09-15 144 xsl144X01/primary_doc.xml 0001950047-25-007139 001-41925 251314706 33 6471
2025-09-15 4 4 0001193125-25-202873 5152
2025-09-09 8-K 8-K 7.01,9.01 0001991792-25-000007 001-41925 251301636 34 19648073 1 1
2025-09-08 4 4 0000950170-25-113556 14295
2025-09-05 144 xsl144X01/primary_doc.xml 0001950047-25-006800 001-41925 251297043 33 4794
2025-09-05 8-K 8-K 7.01,8.01,9.01 0001991792-25-000004 001-41925 251294996 34 259867 1 1
2025-09-04 4 4 0002008157-25-000004 12757
2025-09-04 4 4 0001235862-25-000003 8087
2025-09-03 144 xsl144X01/primary_doc.xml 0001961863-25-000140 001-41925 251290846 33 4560
2025-09-03 144 xsl144X01/primary_doc.xml 0001950047-25-006716 001-41925 251290164 33 5516
2025-08-08 10-Q 10-Q 0000950170-25-105855 001-41925 251198614 34 7723868 1 1
2025-08-08 8-K 8-K 2.02,9.01 0000950170-25-105487 001-41925 251196278 34 386236 1 1
2025-08-06 3 3 0000950170-25-104053 23023
2025-08-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-25-002004 005-94327 251188302 34 10932
2025-07-18 4 4 0000950170-25-096949 8087
2025-07-17 144 xsl144X01/primary_doc.xml 0001950047-25-005089 001-41925 251130893 33 6240
2025-07-11 8-K 8-K 5.02 0000950170-25-095296 001-41925 251119159 34 162258 1 1
2025-06-06 4 4 0000950170-25-083235 5562
2025-06-06 4 4 0000950170-25-083240 5583
2025-06-06 4 4 0000950170-25-083239 5593
2025-06-06 4 4 0000950170-25-083238 5583
2025-06-06 4 4 0000950170-25-083237 5611
2025-06-06 4 4 0000950170-25-083236 5616
2025-06-06 8-K 8-K 5.07 0000950170-25-083088 001-41925 251030847 34 179639 1 1
2025-05-22 4 4 0000950170-25-076339 8086
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-072759 005-94327 25954226 34 13286
2025-05-13 10-Q 10-Q 0000950170-25-069831 001-41925 25937347 34 6782734 1 1
2025-05-13 8-K 8-K 2.02,9.01 0000950170-25-069825 001-41925 25937284 34 419278 1 1
2025-04-29 4 4 0000950170-25-060145 8089
2025-04-28 8-K 8-K 7.01,8.01,9.01 0000950170-25-058956 001-41925 25875947 34 272075 1 1
2025-04-25 ARS ARS 0000950170-25-058345 001-41925 25870077 34 5276157
2025-04-25 DEFA14A DEFA14A 0000950170-25-058344 001-41925 25870068 34 1886243
2025-04-25 DEF 14A DEF 14A 0000950170-25-058342 001-41925 25870055 34 3968569 1 1
2025-04-16 4 4 0000950170-25-054742 5372
2025-04-16 4 4 0000950170-25-054740 5373
2025-04-16 4 4 0000950170-25-054739 5377
2025-04-16 4 4 0000950170-25-054738 5395
2025-04-16 4 4 0000950170-25-054737 5353
2025-03-28 S-3ASR S-3ASR 0001193125-25-067207 333-286230 25787364 33 1335390
2025-03-28 10-K 10-K 0000950170-25-046351 001-41925 25781752 34 28310745 1 1
2025-03-28 8-K 8-K 2.02,9.01 0000950170-25-046335 001-41925 25781463 34 435848 1 1
2025-03-24 8-K 8-K 7.01,8.01,9.01 0000950170-25-043497 001-41925 25762325 34 255182 1 1
2025-03-18 4 4 0000950170-25-041265 8093
2025-03-17 144 xsl144X01/primary_doc.xml 0001950047-25-001969 001-41925 25745121 33 6477
2025-02-19 4 4 0000950170-25-023182 8096
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004201 005-94327 25631347 34 19548
2025-01-28 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-009941 005-94327 25565469 34 25469
2025-01-14 4 4 0000950170-25-005359 8096
2025-01-10 8-K 8-K 5.02 0000950170-25-004168 001-41925 25523163 34 171294 1 1
2024-12-17 4 xslF345X05/form4-12172024_111213.xml 0001415889-24-029664 7470
2024-12-17 4 4 0000950170-24-137319 8074
2024-12-13 424B4 424B4 0001193125-24-278472 333-283725 241548392 33 1130104
2024-12-12 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-12-12 16:00:00 9999999995-24-003769 333-283725 241546608 33 1780
2024-12-11 S-1/A S-1/A 0001193125-24-275552 333-283725 241541608 33 338954
2024-12-11 CORRESP filename1.htm 0001193125-24-274853 12741
2024-12-11 CORRESP filename1.htm 0001193125-24-274852 8299
2024-12-11 S-1 S-1 0001193125-24-274822 333-283725 241540038 33 1249316
2024-12-06 4 4 0000950170-24-134261 10150
2024-12-06 144 xsl144X01/primary_doc.xml 0001950047-24-009508 001-41925 241532747 33 5030
2024-12-05 8-K 8-K 7.01,8.01,9.01 0001193125-24-271116 001-41925 241527855 34 197007 1 1
2024-11-21 UPLOAD filename1.pdf 0000000000-24-012911 377-07557 40091
2024-11-14 DRS filename1.htm 0000950123-24-011900 377-07557 241464261 33 515213
2024-11-12 SC 13G/A UnitedStates_13G__CGoncology.txt 0000932471-24-000976 005-94327 241446999 34 6573
2024-11-12 10-Q 10-Q 0000950170-24-124642 001-41925 241443657 34 6653151 1 1
2024-11-12 8-K 8-K 2.02,9.01 0000950170-24-124636 001-41925 241443613 34 215713 1 1
2024-11-08 SC 13G us1569441009_110824.txt 0002012383-24-003527 005-94327 241439658 34 13786
2024-11-04 SC 13G/A UnitedStates_13G__CGoncology.txt 0000932471-24-000211 005-94327 241421215 34 5638
2024-10-22 SC 13G us1569441009_102224.txt 0002012383-24-001588 005-94327 241387307 34 13774
2024-10-08 4 4 0000950170-24-113418 5353
2024-10-07 4 4 0000950170-24-113320 5327
2024-10-07 4 4 0000950170-24-113314 5304
2024-10-07 4 4 0000950170-24-113311 5344
2024-10-07 4 4 0000950170-24-113310 5353
2024-10-07 4 4 0000950170-24-113308 5380
2024-10-07 4 4 0000950170-24-113304 5347
2024-10-07 4 4 0000950170-24-113299 5328
2024-10-07 4 4 0000950170-24-113297 5376
2024-10-07 4 4 0000950170-24-113290 5395
2024-10-07 4 4 0000950170-24-113282 5375
2024-08-30 4 4 0000950170-24-102496 7771
2024-08-29 144 xsl144X01/primary_doc.xml 0001961863-24-000310 001-41925 241265509 33 4613
2024-08-29 144 xsl144X01/primary_doc.xml 0001961863-24-000309 001-41925 241265503 33 4585
2024-08-29 144 xsl144X01/primary_doc.xml 0001961863-24-000308 001-41925 241265294 33 4613
2024-08-29 144 xsl144X01/primary_doc.xml 0001961863-24-000307 001-41925 241265289 33 4585
2024-08-08 10-Q 10-Q 0000950170-24-093238 001-41925 241185867 34 6212286 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093237 001-41925 241185866 34 227707 1 1
2024-07-22 SC 13G SC 13G 0001193125-24-182242 005-94327 241131926 34 199578
2024-05-24 8-K 8-K 7.01,8.01,9.01 0000950170-24-064309 001-41925 24980887 34 236942 1 1
2024-05-16 4 4 0000950170-24-061276 5374
2024-05-16 3 3 0000950170-24-061188 24091
2024-05-09 8-K 8-K 2.02,9.01 0001193125-24-134805 001-41925 24928707 34 184146 1 1
2024-05-09 10-Q 10-Q 0000950170-24-056196 001-41925 24928358 34 5457319 1 1
2024-05-03 8-K 8-K 8.01 0001193125-24-130800 001-41925 24913710 34 154788 1 1
2024-04-09 SC 13G/A SC 13G/A 0001104659-24-045323 005-94327 24833884 34 112991
2024-04-09 4/A xslF345X05/form4a-04092024_110416.xml 0001415889-24-010609 13014
2024-03-26 10-K 10-K 0000950170-24-036143 001-41925 24780831 34 14687372
2024-03-14 SC 13G SC 13G 0001193125-24-068189 005-94327 24751986 34 44399
2024-02-16 8-K 8-K 5.02 0001193125-24-038506 001-41925 24648680 34 169278 1 1
2024-02-09 SC 13G SC 13G 0001193125-24-030117 005-94327 24615530 34 73915
2024-02-08 SC 13G SC 13G 0001104659-24-012374 005-94327 24610183 34 113361
2024-02-05 SC 13G SC 13G 0001193125-24-024118 005-94327 24596355 34 122533
2024-02-05 SC 13G SC 13G 0001104659-24-010557 005-94327 24595430 34 125264
2024-01-31 4 4 0000950170-24-009435 4450
2024-01-31 4 4 0000950170-24-009432 4406
2024-01-31 4 4 0000950170-24-009429 19023
2024-01-31 4 xslF345X05/form4-01312024_090105.xml 0001415889-24-002062 21672
2024-01-30 8-K 8-K 5.03,8.01,9.01 0001193125-24-018715 001-41925 24575798 34 422415 1 1
2024-01-26 SEC STAFF LETTER filename1.pdf 9999999997-24-000220 63507
2024-01-26 S-8 S-8 0001193125-24-016881 333-276729 24569188 33 969052
2024-01-26 4 4 0000950170-24-007962 5295
2024-01-25 424B4 424B4 0001193125-24-015534 333-276350 24563151 33 4548674
2024-01-24 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-01-24 16:00:00 9999999995-24-000197 333-276350 24558442 33 1779
2024-01-24 3 3 0000950170-24-007178 21467
2024-01-24 3 3 0000950170-24-007176 27308
2024-01-24 3 3 0000950170-24-007173 27386
2024-01-24 3 3 0000950170-24-007171 22312
2024-01-24 3 3 0000950170-24-007170 41750
2024-01-24 3 3 0000950170-24-007167 23798
2024-01-24 3 3 0000950170-24-007166 23934
2024-01-24 3 3 0000950170-24-007164 22391
2024-01-24 3 3 0000950170-24-007163 21247
2024-01-24 3 3 0000950170-24-007157 26847
2024-01-24 3 xslF345X02/form3-01252024_010140.xml 0001415889-24-001783 12042
2024-01-24 S-1MEF S-1MEF 0001193125-24-014437 333-276685 24558210 33 48774
2024-01-24 CERT 8A_Cert_IPO_CGON.pdf 0001354457-24-000028 001-41925 24554535 34 251889
2024-01-23 S-1/A S-1/A 0001193125-24-012523 333-276350 24550428 33 4669349
2024-01-22 CORRESP filename1.htm 0001193125-24-012244 8799
2024-01-22 CORRESP filename1.htm 0001193125-24-012237 7763
2024-01-22 8-A12B 8-A12B 0001193125-24-012233 001-41925 24549513 34 13875
2024-01-18 S-1/A S-1/A 0001193125-24-009621 333-276350 24540053 33 6382844
2024-01-05 CORRESP filename1.htm 0001193125-24-002809 138518
2024-01-02 CORRESP filename1.htm 0001193125-24-000774 32793
2024-01-02 S-1 S-1 0001193125-24-000766 333-276350 24503477 33 7750563
2023-12-18 UPLOAD filename1.pdf 0000000000-23-013792 377-06934 46607
2023-12-04 DRSLTR filename1.htm 0000950123-23-011117 40148
2023-12-04 DRS/A filename1.htm 0000950123-23-011116 377-06934 231464216 33 4659747
2023-11-27 SEC STAFF LETTER filename1.pdf 9999999997-24-000249 64463
2023-11-27 UPLOAD filename1.pdf 0000000000-23-012841 377-06934 52226
2023-10-27 DRS filename1.htm 0000950123-23-009093 377-06934 231356058 33 6051117

Latest XBRL company facts

One latest value per concept from companyfacts (228 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 89.32M 2026-11-04 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
dei EntityPublicFloat Entity Public Float USD 1.70B 2025-06-30 2025 FY 10-K 2026-02-27 0001193125-26-079498
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.73M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177395
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.33M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177395
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 131.07 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177395
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 28.62M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177395
ecd PeoTotalCompAmt PeoTotalCompAmt USD 11.93M 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177395
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 111.7 2025-01-01 2025-12-31 DEF 14A 2026-04-24 0001193125-26-177395
ffd NetFeeAmt NetFeeAmt USD 69,050 2026-08-06 424B5 2026-08-06 0001193125-26-336792
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 1.05B 2026-08-06 424B5 2026-08-06 0001193125-26-336792
ffd TtlFeeAmt TtlFeeAmt USD 148,755 2026-08-06 424B5 2026-08-06 0001193125-26-336792
ffd TtlOfferingAmt TtlOfferingAmt USD 1.05B 2026-08-06 424B5 2026-08-06 0001193125-26-336792
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-06 424B5 2026-08-06 0001193125-26-336792
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 79,705 2026-08-06 424B5 2026-08-06 0001193125-26-336792
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 562,000 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105855
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 11.33M 2024-09-30 2024 Q3 10-Q 2024-11-12 0000950170-24-124642
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.77M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 7.26M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 35.53M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 2.66M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 3.96M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.57B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 8.46M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 29.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 7.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap Assets Assets USD 1.05B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap AssetsCurrent Assets, Current USD 1.01B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities USD 307,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CapitalizedComputerSoftwareNet Capitalized Computer Software, Net USD 1.30M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 28.25M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 21.84M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 28.25M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -4.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 15.24M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 700.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 89.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 89.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CommonStockValue Common Stock, Value, Issued USD 9,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -196.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 29,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CostOfRevenue Cost of Revenue USD 9.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 8,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 400,000 2024-03-05 2024 Q3 10-Q 2024-11-12 0000950170-24-124642
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-03-28 0000950170-25-046351
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -261,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -278,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.23M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 400,000 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105855
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -17,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetInterestCarryforward Deferred Tax Asset, Interest Carryforward USD 1.80M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 95.49M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 9.90M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 93.26M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 64.43M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 301.70M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration USD 292.20M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 11.30M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration USD 9.50M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 523,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 425,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.92M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 93.29M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 30,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 248,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 1.04M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap Depreciation Depreciation USD 2.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -2.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.25 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.223 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.002 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.026 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure 0.062 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 0 2024-12-31 2024 FY 10-K 2025-03-28 0000950170-25-046351
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 25,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 275,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 60,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year USD 43,000 2025-09-30 2025 Q3 10-Q 2025-11-14 0001193125-25-283000
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 60,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 60,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 60,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 60,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 600,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 530,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 72.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap Goodwill Goodwill USD 10.30M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 14,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap IncomeTaxExaminationInterestAccrued Income Tax Examination, Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxExaminationPenaltiesAccrued Income Tax Examination, Penalties Accrued USD 0 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxExaminationPenaltiesExpense Income Tax Examination, Penalties Expense USD 0 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -270,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 16,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 35.88M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -33.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 315,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -88,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -71,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.94M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -219,000 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105855
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -22,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -4.13M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056196
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 11.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -400,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -978,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 5.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 6.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 142,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap InventoryNet Inventory, Net USD 1.17M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 20.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 1.01M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap LeaseCost Lease, Cost USD 1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 7.38M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.42M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 164,000 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.47M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.49M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 470,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.14M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap Liabilities Liabilities USD 55.70M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.05B 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LiabilitiesCurrent Liabilities, Current USD 46.43M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 3.00M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap LossContingencyDamagesAwardedValue Loss Contingency, Damages Awarded, Value USD 0 2025-07-29 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 956.21M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 405.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -258.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -151.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -196.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -161.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 19.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap NotesAndLoansReceivableNetNoncurrent Financing Receivable, after Allowance for Credit Loss, Noncurrent USD 26.68M 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105855
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 219.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingExpenses Operating Expenses USD 91.00M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105855
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -216.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 6.24M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.13M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 5.11M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingLeasePayments Operating Lease, Payments USD 926,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.26M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.068 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.56M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 6.92M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax Other Comprehensive Income (Loss), before Reclassifications, Net of Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 855,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OtherNoncashIncome Other Noncash Income USD 768,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -139,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -150,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 186,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 197,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 783.40M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336918
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 905.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 26.00M 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336918
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 1.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 529.85M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105855
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 1.33 2024-12-31 2024 FY 10-K 2025-03-28 0000950170-25-046351
us-gaap PreferredStockDividendsIncomeStatementImpact Preferred Stock Dividends, Income Statement Impact USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 21.44M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 406.41M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 391.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 104.63M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 370.52M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-08 0000950170-25-105855
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 649.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 14.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -139.26M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-06 0001193125-26-336918
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 18.89M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 14.93M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 666,000 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap RedeemablePreferredStockDividends Redeemable Preferred Stock Dividends USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 137.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -575.13M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 3.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 3.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 29.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.7 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.63 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.049 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.037 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 188.77M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 17.63 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 100.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 468,690 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 35.96 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 43.31 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 319.90M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 7.14M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 26.09 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number shares 3.54M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 26.09 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 319.90M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 7.14M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 29.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 8.84 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 67.09 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 990.97M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.105 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 38.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 1.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 307.89M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 10.28M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap TradingSecuritiesDebt Debt Securities, Trading USD 956.21M 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD -9.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.87M 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 505,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap UnrecognizedTaxBenefitsPeriodIncreaseDecrease Unrecognized Tax Benefits, Period Increase (Decrease) USD 1.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 36.90M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-27 0001193125-26-079498
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 87.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 87.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-06 0001991792-26-000012

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →